eMedicine Specialties > Ophthalmology > Intraocular Pressure

Glaucoma, Primary Congenital

Author: Gerhard W Cibis, MD, Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas, Kansas City
Coauthor(s): Robert C Urban, Jr, MD, Medical Director, Glaucoma Associates, Oaklake Medical Center; Andrew A Dahl, MD, Director of Ophthalmology Teaching, Mid-Hudson Family Practice Institute, The Institute for Family Health; Assistant Professor of Surgery (Ophthalmology), New York College of Medicine
Contributor Information and Disclosures

Updated: Feb 13, 2009

Introduction

Background

By definition, primary congenital glaucoma is present at birth; however, its manifestations may not be recognized until infancy or early childhood. It is characterized by improper development of the eye's aqueous outflow system, leading to increased intraocular pressure (IOP), with consequent damage to ocular structures, resulting in loss of vision. Although the disease is relatively rare, the impact on visual development can be extreme. Early recognition and appropriate therapy of the glaucoma can significantly improve the child's visual future.

Pathophysiology

Primary congenital glaucoma is restricted to a developmental abnormality that affects the trabecular meshwork. This serves to distinguish it from other childhood glaucomas associated with other ocular and systemic congenital abnormalities, as well as childhood glaucomas that may be secondary to other ocular disorders, such as inflammation, trauma, and tumors.

Frequency

United States

Primary congenital glaucoma is estimated to affect fewer than 0.05% of ophthalmic patients, although patients with the disease account for a significantly higher incidence in institutions for the blind, with various studies suggesting from 2-15%.

Mortality/Morbidity

The disease is bilateral in approximately 75% of cases.

Race

Congenital glaucoma affects all races

Sex

Male patients are found to have a higher incidence of the disease, comprising approximately 65% of cases.

Age

Primary congenital glaucoma usually is diagnosed at birth or shortly thereafter, and most cases are diagnosed in the first year of life.

Clinical

History

The classic triad of manifestations, any one of which should arouse suspicion of glaucoma in an infant or young child, includes epiphora, photophobia, and blepharospasm.

Physical

Complete ophthalmologic examination

  • Externally, changes within the cornea, especially within the first few years of life, provide strong additional support for the diagnosis.
  • The average horizontal corneal diameter at birth is less than 10.5 millimeters. Distention of the globe in response to elevated intraocular pressure leads to enlargement of the cornea. If the corneoscleral junction is more than 12 millimeters in diameter in the first year of life, it is highly suggestive of glaucoma. Grossly, this is more evident in asymmetric cases.
  • Corneal edema may be a direct result of the elevated intraocular pressure, producing a corneal haze that clears with normalization of the pressure. Haab striae represent tears in the Descemet membrane as a result of elevated intraocular pressure. In advanced cases, a dense opacification of the corneal stroma may occur secondary to the corneal edema, and it may persist, despite reduction of the intraocular pressure.
  • The early presence of glaucoma may deepen the anterior chamber. Because of the frequent occurrence of iris abnormalities in many types of both primary and secondary childhood glaucomas, the iris and angles always should be studied carefully and with thorough gonioscopy.
  • By the time that glaucoma is diagnosed in a child, the optic nerve head is usually abnormal. Variable cupping is present, usually annular in form, with nasalization of vessels and preservation of the well-vascularized rim. Pallor is first seen temporally when present at an advanced stage.
  • Tonometry often can be accomplished in a child's eye with a handheld instrument, such as a Perkins tonometer or a Tono-Pen. Accuracy of intraocular pressure measurements taken in the office may be artificially elevated from straining.

Causes

Most cases of primary congenital glaucoma are sporadic in occurrence. However, evidence exists suggesting that the disease may be transmitted through an autosomal recessive pattern, with variable penetrance, or a polygenic inheritance pattern.

CYP1B1, the gene encoding cytochrome P4501B1 (P450, family I, sub family B, polypeptide 1) is associated with primary congenital glaucoma. GLC3B located on band 1p36 and GLC3C located on band 14q24.3 are loci that are linked to primary congenital glaucoma, but the genes are unknown.

The incidence of CYP1B1 in familial cases is 93% in Saudi Arabia, 50% in Brazil, and 20-30% in ethnically mixed populations, and its incidence in nonfamilial (simplex) cases is 10-15%.  Mice with this defect have structural abnormalities of the drainage system resembling those seen in humans.

More on Glaucoma, Primary Congenital

Overview: Glaucoma, Primary Congenital
Differential Diagnoses & Workup: Glaucoma, Primary Congenital
Treatment & Medication: Glaucoma, Primary Congenital
Follow-up: Glaucoma, Primary Congenital
References
[ CLOSE WINDOW ]

References

  1. Gupta V, Jha R, Srinivasan G, Dada T, Sihota R. Ultrasound biomicroscopic characteristics of the anterior segment in primary congenital glaucoma. J AAPOS. Dec 2007;11(6):546-50. [Medline].

  2. Tamcelik N, Ozkiris A. Long-term results of viscotrabeculotomy in congenital glaucoma: comparison to classical trabeculotomy. Br J Ophthalmol. Jan 2008;92(1):36-9. [Medline].

  3. Bejjani BA. Primary congenital glaucoma. Gene Tests. Available at http://www.genetests.org/. Accessed September 30, 2004.

  4. DP Edward, Fajarananant TS, et al. A comprehensive update on congenital glaucoma. Current Pediatric Reviews. Feb 2008;4(1):19-30.

  5. Sarfarazi Mansoor , inventors; U of Connecticut. Diagnosis of Primary Congenital Glaucoma. US patent 6207394. March 27 2001.

[ CLOSE WINDOW ]

Further Reading

[ CLOSE WINDOW ]

Keywords

primary congenital glaucoma, childhood glaucomas, glaucoma in children, increased intraocular pressure, increased IOP, optic nerve damage, vision loss, blindness, aqueous outflow

[ CLOSE WINDOW ]

Contributor Information and Disclosures

Author

Gerhard W Cibis, MD, Clinical Professor, Director of Pediatric Ophthalmology Service, Department of Ophthalmology, University of Kansas, Kansas City
Gerhard W Cibis, MD is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, and American Ophthalmological Society
Disclosure: Nothing to disclose.

Coauthor(s)

Robert C Urban, Jr, MD, Medical Director, Glaucoma Associates, Oaklake Medical Center
Robert C Urban, Jr, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Ophthalmology
Disclosure: Nothing to disclose.

Andrew A Dahl, MD, Director of Ophthalmology Teaching, Mid-Hudson Family Practice Institute, The Institute for Family Health; Assistant Professor of Surgery (Ophthalmology), New York College of Medicine
Andrew A Dahl, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Neil T Choplin, MD, Adjunct Clinical Professor, Department of Surgery, Section of Ophthalmology, Uniformed Services University of Health Sciences
Neil T Choplin, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, Association for Research in Vision and Ophthalmology, and California Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Simon K Law, MD, PharmD, Assistant Professor of Ophthalmology, Jules Stein Eye Institute; Chief of Section of Ophthalmology Surgical Services, Department of Veterans Affairs Healthcare Center, West Los Angeles
Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Association for Research in Vision and Ophthalmology
Disclosure: Nothing to disclose.

Managing Editor

Martin B Wax, MD, Clinical Professor, Department of Ophthalmology, University of Texas Southwestern Medical School; Vice President, Ophthalmology Research and Development, Head, Ophthalmology Discovery Research, Alcon Labs, Inc
Martin B Wax, MD is a member of the following medical societies: American Academy of Ophthalmology, American Glaucoma Society, and Society for Neuroscience
Disclosure: Alcon Labs Salary Employment

CME Editor

Lance L Brown, OD, MD, Ophthalmologist, Affiliated With Freeman Hospital and St John's Hospital, Regional Eye Center, Joplin, Missouri
Disclosure: Nothing to disclose.

Chief Editor

Hampton Roy Sr, MD, Associate Clinical Professor, Department of Ophthalmology, University of Arkansas for Medical Sciences
Hampton Roy Sr, MD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, and Pan-American Association of Ophthalmology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.